MedPath

To Study the Role Of Eranda Siddha Taila vaginal tampoon on cervical dilatation and effacement in Normal delivery in Primipara patient.

Phase 2
Conditions
Health Condition 1: O758- Other specified complications of labor and delivery
Registration Number
CTRI/2022/02/040388
Lead Sponsor
DrTrupti Kalyan Gawade
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Primipara with gestational age of 36 weeks

Age group 19-30 years

Exclusion Criteria

Primipara having any Garbhopadrava and

Garbhavyapada

Garbhopadrava means pregnancy induced any abnormality or pre-existing any disease.

Garbhavyapada means abnormality related to baby.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To delivered healthy baby from a healthy mother,without any complications by achieving the goal of sukhprasavay.Timepoint: To provide good obstetric care that will result in good fetal outcome within 4 weeks from 36 wks onwards till labour pain start.
Secondary Outcome Measures
NameTimeMethod
ï?½To provide good obstetric care that will result in good fetal outcome by reducing the fear of a mother regarding labor. <br/ ><br>ï?½To reduce the rate of invasive or operative deliveries & their related complications.Timepoint: 18 months of study period
© Copyright 2025. All Rights Reserved by MedPath